https://medic.usm.my/expertsppsp
Education records:
PhD in Biochemical Sciences, University of Surrey (2013)
MSc Clinical Biochemistry with Molecular Biology, University of Surrey (2008)
Bachelor of Health Sciences (Biomedicine) (Honours), UniversitiSainsMalaysia (2005)
Research interest:
Exploration of cell cycle regulation for biomarker development in drug-resistant cancer
Publications:
Proteomics analysis of ovarian cancer cell lines and tissues reveals drug resistance-associated proteins (Cancer Genomics-Proteomics 2017). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267499/
Safuwan, N. M., T. Crook, et al. (2012). "Cell Cycle Regulation Changes in Drug-Resistant Cancers." European Journal of Cancer 48: 160. https://www.researchgate.net/publication/288365405_521_Cell_Cycle_Regulation_Changes_in_Drug-Resistant_Cancers
Epigenetics, cell cycle and drug-resistant ovarian cancer (Cancer Research 2012). https://cancerres.aacrjournals.org/content/72/8_Supplement/795
Coley, H., N. A. M. Safuwan, et al. (2012). "The cyclin-dependent kinase inhibitor p57Kip2 is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclibin ovarian cancer." British journal of cancer 106(3): 482-489. https://www.nature.com/articles/bjc2011566
Absence of p57Kip2 as a new biomarker of chemoresponsiveness in epithelial ovarian cancer (Cancer Research 2010). https://cancerres.aacrjournals.org/content/70/8_Supplement/3737
Contact details:
Email:
Phone (office): +09767 6475
